EHA 2022 | RIC vs MAC in MRD-positive & MRD-negative patients with AML
Nico Gagelmann
• 9 Jun 2022
Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, comments on the use of reduced-intensity conditioning (RIC) and myeloablative conditioning (MAC) in patients with acute myeloid leukemia (AML) who are measurable residual disease (MRD)-positive or MRD-negative. Whilst studies have suggested that MRD-positive patients should be treated with MAC, it is necessary to conduct a prospective study to determine the best conditioning regimen for MRD-negative patients. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
